Pravin Badhe

No ORCID on file · 1 paper in corpus
2025
·doi:10.20944/preprints202510.0629.v1

Estrogen Receptor 1 (ESR1) remains a cornerstone therapeutic target in estrogen receptor-positive (ER+) breast cancer, driving ~70% of cases through dysregulated endocrine signalling. This study leverages the Swalife PromptStudio platform, …